This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated FOXG1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-FOXG1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~52.4 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | — | |
| Caveat | — | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A01852-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Target-positive lysate and matched negative control (standard starting point) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A01852-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
FOXG1 is predicted at 52.4 kDa; no empirical band size is supplied, and its annotated features do not demonstrate altered migration.
| Single band near 52.4 kDa | Consistent with the predicted FOXG1 mass; band identity still needs confirmation |
| Band in mouse brain lysate | Consistent with the reported FOXG1 detection in that sample; its apparent mass was not supplied |
| Band enriched in a nuclear fraction | Consistent with FOXG1's annotated nuclear location |
| Band well above 52.4 kDa | Its identity or altered migration needs confirmation; no size-raising feature is annotated |
| Predicted molecular mass | Places the reference size at 52.4 kDa |
| 489-residue sequence | Defines the full-length protein underlying the predicted mass |
| No annotated glycosylation sites | Provides no documented glycan-related size increase |
| No annotated signal peptide or propeptide | Provides no documented cleavage-related size decrease |
| One listed isoform | Provides no basis for predicting separate isoform bands |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | FOXG1 may be below detection in the sample | Check a mouse brain lysate positive control and enrich the nuclear fraction |
| Band higher than expected | No annotated feature establishes the size increase | Check the molecular weight marker and confirm band identity with FOXG1 depletion |
| Band lower than expected | No annotated processing event establishes a smaller product | Confirm band identity with FOXG1 depletion |
| Multiple bands | The single listed isoform does not explain distinct bands | Compare bands before and after FOXG1 depletion |
| Weak or no signal | Nuclear FOXG1 may be poorly represented in the tested extract | Check extraction and test a nuclear fraction alongside mouse brain lysate |
| Fragments below expected size | Possible sample degradation is not established by the supplied features | Prepare fresh lysate with protease inhibitors and confirm FOXG1 identity |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for FOXG1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-FOXG1 antibodies have WB images: A01852-1 in mouse brain lysate, A01852-2 in human U251 cells and rat and mouse brain lysates, and A01852 in rat brain lysate. These are tested examples; no publication evidence is supplied.
Which to pick: Match the antibody to your sample: A01852-2 shows human U251 cells and rat and mouse brain lysates, with a reported band near 52 kDa. A01852-1 shows mouse brain lysate; A01852 shows rat brain lysate.